KLF5, a new player and new target in the permanently changing set of pancreatic cancer molecular drivers

被引：0
|
作者：
M. V. Zinovyeva
M. B. Kostina
I. P. Chernov
L. G. Kondratyeva
E. D. Sverdlov
机构：
[1] Russian Academy of Sciences,Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
来源：
Russian Journal of Bioorganic Chemistry | 2016年 / 42卷
关键词：
pancreatic ductal adenocarcinoma; KLF5; carcinogenesis; master genes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pancreatic cancer is one of the most aggressive tumor types characterized by chemotherapy resistance and high metastatic activity. Recent studies revealed new genes, which are likely to be actively involved in the regulation of the processes occurring in the pancreas, as well as in the development of cancer in this organ. This review is devoted to the description of one of the recently revealed genes, KLF5, which seems to be a promising target for therapeutic intervention in the most widespread type of pancreatic cancer, ductal adenocarcinoma.
引用
收藏
页码：606 / 611
页数：5
相关论文
共 50 条
  • [1] KLF5, a new player and new target in the permanently changing set of pancreatic cancer molecular drivers
    Zinovyeva, M. V.
    Kostina, M. B.
    Chernov, I. P.
    Kondratyeva, L. G.
    Sverdlov, E. D.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2016, 42 (06) : 606 - 611
  • [2] Tyrosine Sulfation: A New Player and Potential Target in Pancreatic Cancer
    Zhang, Yaqing
    Di Magliano, Marina Pasca
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2023, 16 (03): : 501 - 502
  • [3] Abrogation of KLF5 sensitizes BRCA1- proficient pancreatic cancer to PARP inhibition
    Zhang, Zheng
    Liu, Yuxin
    Xu, Yaolin
    Xu, Zijin
    Jia, Jinbin
    Jin, Yun
    Wang, Wenquan
    Liu, Liang
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2024, 56 (04): : 576 - 585
  • [4] Small molecule KLF5 inhibitors: New agents for treating colorectal cancers
    Wang, Chao
    Eguizabal, Ainara Ruiz de Sabando
    He, Yuanjun
    Bannister, Thomas
    Garcia-Barros, Monica
    Bialkowska, Agnieszka B.
    Yang, Vincent W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [5] PLA2G16is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer
    Xia, Wei
    Bai, Hansong
    Deng, Ying
    Yang, Yi
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (21) : 12642 - 12655
  • [6] Correlation between Expression of KLF5 and ZEB1 Transcription Factor Genes in Pancreatic Cancer
    M. V. Zinovyeva
    L. G. Nikolaev
    L. G. Kondratyeva
    T. V. Vinogradova
    E. D. Sverdlov
    Doklady Biochemistry and Biophysics, 2018, 481 : 219 - 221
  • [7] Correlation between Expression of KLF5 and ZEB1 Transcription Factor Genes in Pancreatic Cancer
    Zinovyeva, M. V.
    Nikolaev, L. G.
    Kondratyeva, L. G.
    Vinogradova, T. V.
    Sverdlov, E. D.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2018, 481 (01) : 219 - 221
  • [8] Overexpression of KLF5 is associated with poor survival and G1/S progression in pancreatic cancer
    Li, Yilong
    Kong, Rui
    Chen, Hongze
    Zhao, Zhongjie
    Li, Le
    Li, Jiating
    Hu, Jisheng
    Zhang, Guangquan
    Pan, Shangha
    Wang, Yongwei
    Wang, Gang
    Chen, Hua
    Sun, Bei
    AGING-US, 2019, 11 (14): : 5035 - 5057
  • [9] Fatty pancreas and pancreatic cancer: a new player on the field?
    Sbeit, Wisam
    Mari, Amir
    Pellicano, Rinaldo
    Khoury, Tawfik
    MINERVA GASTROENTEROLOGY, 2021, 67 (01): : 65 - 66
  • [10] The miR-1305/KLF5 negative regulatory loop affects pancreatic cancer cell proliferation and apoptosis
    Zhou, Yufu
    Tang, Yulin
    Huang, Feizhou
    Wang, Zhichao
    Wen, Zhengbin
    Fang, Qi
    Wang, Changfa
    HUMAN CELL, 2025, 38 (02)
12345